BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7055248)

  • 1. Plasma imipramine concentrations in patients receiving concomitant fluphenazine decanoate.
    Siris SG; Cooper TB; Rifkin AE; Brenner R; Lieberman JA
    Am J Psychiatry; 1982 Jan; 139(1):104-6. PubMed ID: 7055248
    [No Abstract]   [Full Text] [Related]  

  • 2. Patterns of plasma imipramine-desipramine concentrations in patients receiving concomitant fluphenazine decanoate.
    Siris SG; Adan F; Lee A; Cooper TB; Mandeli J; Casey E
    J Clin Psychiatry; 1988 Feb; 49(2):64-5. PubMed ID: 3338977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antidepressants in the treatment of post-psychotic depression in schizophrenia: drug interactions and other considerations.
    Siris SG; Sellew AP; Frechen K; Cooper TB; Mandell J; Casey E
    Clin Chem; 1988 May; 34(5):837-40. PubMed ID: 3286051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted treatment of depression-like symptoms in schizophrenia.
    Siris SG; Adan F; Cohen M; Mandeli J; Aronson A; Fasano-Dube B
    Psychopharmacol Bull; 1987; 23(1):85-9. PubMed ID: 3602335
    [No Abstract]   [Full Text] [Related]  

  • 5. Maintenance imipramine therapy for secondary depression in schizophrenia. A controlled trial.
    Siris SG; Bermanzohn PC; Mason SE; Shuwall MA
    Arch Gen Psychiatry; 1994 Feb; 51(2):109-15. PubMed ID: 7905256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring plasma levels of fluphenazine during chronic therapy with fluphenazine decanoate.
    Miller RS; Peterson GM; McLean S; Westhead TT; Gillies P
    J Clin Pharm Ther; 1995 Apr; 20(2):55-62. PubMed ID: 7650075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjunctive imipramine in the treatment of postpsychotic depression. A controlled trial.
    Siris SG; Morgan V; Fagerstrom R; Rifkin A; Cooper TB
    Arch Gen Psychiatry; 1987 Jun; 44(6):533-9. PubMed ID: 3555386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haloperidol decanoate as a replacement for maintenance therapy with intramuscular fluphenazine decanoate in schizophrenia and other chronic psychoses.
    Roose K
    Acta Psychiatr Belg; 1982; 82(2):216-23. PubMed ID: 7180558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuation and maintenance treatment trials of adjunctive imipramine therapy in patients with postpsychotic depression.
    Siris SG; Strahan A
    J Clin Psychiatry; 1988 Nov; 49(11):439-40. PubMed ID: 3182733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized clinical trial of haloperidol decanoate and fluphenazine decanoate in the outpatient treatment of schizophrenia.
    Chouinard G; Annable L; Campbell W
    J Clin Psychopharmacol; 1989 Aug; 9(4):247-53. PubMed ID: 2570086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative trial of haloperidol decanoate and fluphenazine decanoate in chronic schizophrenic patients.
    Wistedt B
    Int Clin Psychopharmacol; 1986 Jul; 1 Suppl 1():15-23. PubMed ID: 3549878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjunctive imipramine maintenance treatment in schizophrenic patients with remitted postpsychotic depression.
    Siris SG; Cutler J; Owen K; Mason S; Gingerich S; Lang MP
    Am J Psychiatry; 1989 Nov; 146(11):1495-7. PubMed ID: 2817126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative study of pipothiazine palmitate and fluphenazine decanoate in the maintenance of remission of schizophrenia.
    Leong OK; Wong KE; Tay WK; Gill RC
    Singapore Med J; 1989 Oct; 30(5):436-40. PubMed ID: 2575796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical observation on the effect of domestic fluphenazine decanoate in the treatment of schizophrenia---report of 431 cases (author's transl)].
    Zhang YF
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1981 Aug; 14(3):182-5. PubMed ID: 7333179
    [No Abstract]   [Full Text] [Related]  

  • 15. Plasma levels of neuroleptic in patients receiving depot fluphenazine.
    Cohen BM; Waternaux C; Chouinard G; Sommer BR; Jones B
    J Clin Psychopharmacol; 1985 Dec; 5(6):328-32. PubMed ID: 4066997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experience with fluphenazine decanoate in the management of chronic schizophrenic outpatients.
    Gaby N; Lefkowitz D; Israel JR
    N C Med J; 1982 Sep; 43(9):641-4. PubMed ID: 6958987
    [No Abstract]   [Full Text] [Related]  

  • 17. Weight gain and prolactin levels in patients on long-term antipsychotic medication: a double-blind comparative trial of haloperidol decanoate and fluphenazine decanoate.
    Cookson JC; Kennedy NM; Gribbon D
    Int Clin Psychopharmacol; 1986 Jul; 1 Suppl 1():41-51. PubMed ID: 3549879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical significance of depot fluphenazine decanoate in therapy of acute psychotic disorders].
    Ngui PW
    Seishin Shinkeigaku Zasshi; 1983; 85(9):635-9. PubMed ID: 6676769
    [No Abstract]   [Full Text] [Related]  

  • 19. The use of fluphenazine decanoate (Modecate)depot therapy in outpatient schizophrenics-a retrospective study.
    Tan CT; Ong TC; Chee KT
    Singapore Med J; 1981 Aug; 22(4):214-8. PubMed ID: 7323829
    [No Abstract]   [Full Text] [Related]  

  • 20. [Flufenazine decanoate in the ambulatory treatment of schizophrenic patients].
    Populin M; De Vanna M; Poldrugo F
    Minerva Psichiatr; 1981; 22(2):85-92. PubMed ID: 7022095
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.